Literature DB >> 6699943

Characterization of a host range mutant of human adenovirus 12 defective in early region 1B.

Y Fukui, K Shiroki, I Saito, H Shimojo.   

Abstract

We isolated an adenovirus 12 early region 1B mutant (in206B) by ligation of the cleaved DNA-protein complex and transfection of human embryo kidney cells with the ligation products. By deduction from the DNA sequencing analysis, the two polypeptides (with molecular weights of 19,000 and 54,000) coded in the early region 1B were fused in this mutant to produce a large polypeptide. This mutant could replicate efficiently in 293 cells but not efficiently in KB or human embryo kidney cells. In KB cells, viral DNA replication could not be detected after infection with in206B. In human embryo kidney cells, viral DNA replication did occur, but the transition of viral mRNA patterns from early to late did not occur even after DNA replication, resulting in failure to produce the late polypeptides. These results indicate that the early region 1B products may be involved in both viral DNA replication and regulation of transcription.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699943      PMCID: PMC255592     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

2.  Establishment and characterization of rat cell lines transformed by restriction endonuclease fragments of adenovirus 12 DNA.

Authors:  K Shiroki; H Handa; H Shimojo; S Yano; S Ojima; K Fujinaga
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

3.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

4.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  Proposed nomenclature for mutants of adenoviruses.

Authors:  H S Ginsberg; J F Williams; W H Doerfler; H Shimojo
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

Authors:  T Harrison; F Graham; J Williams
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

9.  Isolation of transformation-defective, replication-nondefective early region 1B mutants of adenovirus 12.

Authors:  Y Fukui; I Saito; K Shiroki; H Shimojo
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

10.  Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA.

Authors:  A J Van der Eb; C Mulder; F L Graham; A Houweling
Journal:  Gene       Date:  1977       Impact factor: 3.688

View more
  3 in total

1.  Adenovirus type 12 E1B 19-kilodalton protein is not required for oncogenic transformation in rats.

Authors:  C Edbauer; C Lamberti; J Tong; J Williams
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  An insertion mutation in the adenovirus type 12 early region 1A 13S mRNA unique region.

Authors:  K Ohshima; K Shiroki
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  The adenovirus type 12 early-region 1B 58,000-Mr gene product is required for viral DNA synthesis and for initiation of cell transformation.

Authors:  K Shiroki; K Ohshima; Y Fukui; H Ariga
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.